RESEARCH
started working unpaid and eventually produced a series of about 16 sporeless oyster mushroom varieties, which we started growing. Naturally, everyone was interested. In 2019, we established a programme with four large spawn producers we often collaborate with that allowed them to trial these varieties internally if they contri- buted financially and shared the feedback on the performance with us. Based on those results, the four companies could, exclusively, decide which varieties they wanted to license for commercial, large scale production. Those negotiations are not always easy, and we have to balance the commercial interests, as of course there is a lot at stake. But ultimately the efforts resulted in the Karabella and Purati. After ten years of research this was a moment of victory for us, and in fact for the growers too. We achieved our aim and there was a significant impact for the sector, but we still find it difficult to understand why funding for such an important research project wasn’t made available sooner.” Van Peer says there is potential for further deve- lopment of the new varieties. “There is still so much to achieve through breeding, such as better shelf life properties, colour or protein content.”
Achievements That brings us to the ongoing research and the recent achievements at Plant Breeding. And it’s quite a list. For example, WUR has developed a so-called LAMP test; the principle of on-farm
identification of a variety (previously published in MB). This new technology contributes to variety protection and innovation and the deve- lopment of new varieties. New research areas have also been emerged in recent years. “For example, a line of research into fungal protein and fermentation, a line of research into fungal materials and an extension of the line of research into the application of mushroom fungi for the valorisation of residual flows. The development of mushroom-producing fungi for material or food purposes is particularity promising and is an exci- ting research area, which is still in its infancy.” New technologies are also applied for research and breeding: CRISPR CAS9 and non-GMO mutagenesis for new germ plasma. Van Peer also mentions internal projects that focus on products and strategic knowledge, such as peat substitutes for casing soil (“we have found a wonderful solution, but want to protect it first”), a sporeless shiitake variety (see above), new breeding techniques for mushrooms, expansion of the strain collection (now >200 species) and - together with sector partners - research into a mushroom that helps boost the immune system. “And finally, there are all kinds of collaborations, including internationally, and we work continuously on developing basic knowledge in the field of strain stability (why varieties behave inconsistently), vegetative incompatibility (why varieties are incompati- ble) and viruses in mushrooms.” Van Peer believes there are huge opportunities for mushroom research and for the sector. “Simply the possibility of using mushrooms as medicines in the future would represent a significant breakthrough.”
The current mushroom team in Wageningen, with Arend van Peer in the middle, Johan Baars (behind him) and Karin Scholtmeijer and Kirsten van Niekerk (to the right of him).
52 MUSHROOM BUSINESS
Optimism Despite the challenges for the Wageningen research group remaining similar to when he started in 2018 and, as illustrated by the above, and his desire to achieve more in partnership with the sector, Arend van Peer is optimistic and clearly enjoys his work as a team leader. “I am immensely proud of what my team does. We have experienced some radical changes in staffing over the past eight years, setbacks with long-term illness, major shifts in the market we source research projects from, and the development of new, additional lines of research. Thanks to the massive commitment of all the members, we have created a close-knit team that offers a broad range of expertise in the field of mushrooms. This certainly makes all the time and energy we devote to our work worthwhile.” Karin adds:“The ‘highs’ of the work make up for all our efforts”, and, laughing: “We’re not in it for the money after all.”
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56